2WHO. Women and tobacco. World Health Organization, Geneva,1992.22-23.
3The Global Youth Tobacco Survey Collaborative Group. Tobacco use among youth: a cross country comparison. Tob Control, 2002, 11:252-270.
4Office on Smoking and Health, CDC. Selected cigarette smoking initiation a quitting behaviours among high school students -United States, 1997.MMWR,1998,47:229-233.
5Crump C, Packer L, Gfroerer J. Incidence of initiation of cigarette smoking - United States, 1965-1996. MMWR, 1998, 47: 837-840.
6Jha P,Novotny TE,Feachem R. The role of governments in global tobacco control. In: Abedian I,van der Merwe R,Wilkins N,et al,eds. The economics of tobacco control. Towards an Optimal Policy Mix. 1st ed. Applied Fiscal Research Center, University of Cape Town, 1998.41-43.
7WHO. Tobacco or health: a global status report. Geneva: World Health Organization, 1997.
8The American cancer society Inc. Tobacco control country profiles,2000.
9KIKUCHI T,TOTTORI K, UWAHODO Y, et al. 7-(4-[4-(2,3-Dichlorophenyl) -1 -piperazinyl ] butyloxy ) -3, 4-dihydro-2 ( 1H ) -quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity [J]. J Pharmacol Exp Ther, 1995, 274( 1 ): 329-336.
7Anthony D,Nick Cpatel,Lynn C. Aripiprazole: a comprehensive re-view of its pharmacology, clinical efficacy, and tolerability[J].Clinical Therapeutics,2004,3(03):432-434.
8Potkin SG,Saha AR, Kujawa MJ, et al. Aripiprazole, an antipsychoticwith a novel mechanism of action, and risperidone vs place-bo in patients with schizophrenia and schizoaffective disorder[J].Archives of General Psychiatry ,2003,2(07):631-633.
10De LJ, Diaz FJ. A meta - analysis of worldwide studies demon- strates an association between schizophrenia and tobacco smoking behaviors[J].Schizophrenia Research,2005,76(2 - 3) : 135 - 257.
